William Blair downgraded Augmedix to Market Perform from Outperform after the company entered into a definitive agreement to be acquired by Commure for $2.35 per share in cash.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AUGX:
- Augmedix to Join Forces with Commure
- Augmedix Discusses AI Tool Success and Expansion Plans
- Augmedix says Go ED has met HCA’s criteria for expansion
- Emergency Services Inc. Partners with Augmedix to Introduce Generative AI Solution That Relieves Clinician Burnout in Emergency Departments
- Augmedix, Emergency Services team to introduce GenAI solution